474 related articles for article (PubMed ID: 12481159)
1. Wnt/beta-catenin/tcf signaling: a critical pathway in gastrointestinal tumorigenesis.
Kolligs FT; Bommer G; Göke B
Digestion; 2002; 66(3):131-44. PubMed ID: 12481159
[TBL] [Abstract][Full Text] [Related]
2. The Yin-Yang of TCF/beta-catenin signaling.
Barker N; Morin PJ; Clevers H
Adv Cancer Res; 2000; 77():1-24. PubMed ID: 10549354
[TBL] [Abstract][Full Text] [Related]
3. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1.
Satoh S; Daigo Y; Furukawa Y; Kato T; Miwa N; Nishiwaki T; Kawasoe T; Ishiguro H; Fujita M; Tokino T; Sasaki Y; Imaoka S; Murata M; Shimano T; Yamaoka Y; Nakamura Y
Nat Genet; 2000 Mar; 24(3):245-50. PubMed ID: 10700176
[TBL] [Abstract][Full Text] [Related]
4. Axin, an inhibitor of the Wnt signalling pathway, interacts with beta-catenin, GSK-3beta and APC and reduces the beta-catenin level.
Nakamura T; Hamada F; Ishidate T; Anai K; Kawahara K; Toyoshima K; Akiyama T
Genes Cells; 1998 Jun; 3(6):395-403. PubMed ID: 9734785
[TBL] [Abstract][Full Text] [Related]
5. ITF-2, a downstream target of the Wnt/TCF pathway, is activated in human cancers with beta-catenin defects and promotes neoplastic transformation.
Kolligs FT; Nieman MT; Winer I; Hu G; Van Mater D; Feng Y; Smith IM; Wu R; Zhai Y; Cho KR; Fearon ER
Cancer Cell; 2002 Mar; 1(2):145-55. PubMed ID: 12086873
[TBL] [Abstract][Full Text] [Related]
6. Regulation of cyclooxygenase-2 expression by the Wnt and ras pathways.
Araki Y; Okamura S; Hussain SP; Nagashima M; He P; Shiseki M; Miura K; Harris CC
Cancer Res; 2003 Feb; 63(3):728-34. PubMed ID: 12566320
[TBL] [Abstract][Full Text] [Related]
7. Alterations of beta-catenin and Tcf-4 instead of GSK-3beta contribute to activation of Wnt pathway in hepatocellular carcinoma.
Cui J; Zhou X; Liu Y; Tang Z; Romeih M
Chin Med J (Engl); 2003 Dec; 116(12):1885-92. PubMed ID: 14687479
[TBL] [Abstract][Full Text] [Related]
8. A possible role for the WNT-1 pathway in oral carcinogenesis.
Lo Muzio L
Crit Rev Oral Biol Med; 2001; 12(2):152-65. PubMed ID: 11345525
[TBL] [Abstract][Full Text] [Related]
9. Elevated expression of Wnt antagonists is a common event in hepatoblastomas.
Koch A; Waha A; Hartmann W; Hrychyk A; Schüller U; Waha A; Wharton KA; Fuchs SY; von Schweinitz D; Pietsch T
Clin Cancer Res; 2005 Jun; 11(12):4295-304. PubMed ID: 15958610
[TBL] [Abstract][Full Text] [Related]
10. gamma-catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of beta-catenin.
Kolligs FT; Kolligs B; Hajra KM; Hu G; Tani M; Cho KR; Fearon ER
Genes Dev; 2000 Jun; 14(11):1319-31. PubMed ID: 10837025
[TBL] [Abstract][Full Text] [Related]
11. TCF: Lady Justice casting the final verdict on the outcome of Wnt signalling.
Brantjes H; Barker N; van Es J; Clevers H
Biol Chem; 2002 Feb; 383(2):255-61. PubMed ID: 11934263
[TBL] [Abstract][Full Text] [Related]
12. Hepatic adenomas: analysis of sex steroid receptor status and the Wnt signaling pathway.
Torbenson M; Lee JH; Choti M; Gage W; Abraham SC; Montgomery E; Boitnott J; Wu TT
Mod Pathol; 2002 Mar; 15(3):189-96. PubMed ID: 11904335
[TBL] [Abstract][Full Text] [Related]
13. Frequent alterations in the Wnt signaling pathway in colorectal cancer with microsatellite instability.
Shimizu Y; Ikeda S; Fujimori M; Kodama S; Nakahara M; Okajima M; Asahara T
Genes Chromosomes Cancer; 2002 Jan; 33(1):73-81. PubMed ID: 11746989
[TBL] [Abstract][Full Text] [Related]
14. Frequent alterations of the beta-catenin and TCF-4 genes, but not of the APC gene, in colon cancers with high-frequency microsatellite instability.
Fukushima H; Yamamoto H; Itoh F; Horiuchi S; Min Y; Iku S; Imai K
J Exp Clin Cancer Res; 2001 Dec; 20(4):553-9. PubMed ID: 11876551
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of Icat induces G(2) arrest and cell death in tumor cell mutants for adenomatous polyposis coli, beta-catenin, or Axin.
Sekiya T; Nakamura T; Kazuki Y; Oshimura M; Kohu K; Tago K; Ohwada S; Akiyama T
Cancer Res; 2002 Jun; 62(11):3322-6. PubMed ID: 12036951
[TBL] [Abstract][Full Text] [Related]
16. Subcellular distribution of Wnt pathway proteins in normal and neoplastic colon.
Anderson CB; Neufeld KL; White RL
Proc Natl Acad Sci U S A; 2002 Jun; 99(13):8683-8. PubMed ID: 12072559
[TBL] [Abstract][Full Text] [Related]
17. Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer.
Sparks AB; Morin PJ; Vogelstein B; Kinzler KW
Cancer Res; 1998 Mar; 58(6):1130-4. PubMed ID: 9515795
[TBL] [Abstract][Full Text] [Related]
18. The control of beta-catenin and TCF during embryonic development and cancer.
Waltzer L; Bienz M
Cancer Metastasis Rev; 1999; 18(2):231-46. PubMed ID: 10728986
[TBL] [Abstract][Full Text] [Related]
19. Negative regulation of the Wnt-beta-catenin pathway by the transcriptional repressor HBP1.
Sampson EM; Haque ZK; Ku MC; Tevosian SG; Albanese C; Pestell RG; Paulson KE; Yee AS
EMBO J; 2001 Aug; 20(16):4500-11. PubMed ID: 11500377
[TBL] [Abstract][Full Text] [Related]
20. P53 gene and Wnt signaling in benign neoplasms: beta-catenin mutations in hepatic adenoma but not in focal nodular hyperplasia.
Chen YW; Jeng YM; Yeh SH; Chen PJ
Hepatology; 2002 Oct; 36(4 Pt 1):927-35. PubMed ID: 12297840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
